Menu

• Ask a Health Expert about ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED
• Post Your Side Effect related to ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED
• ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED and FDA Warnings
• ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED in Patients Wiki
• Report ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED in Drug Side Effect Survey

ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED side effect

What is ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Prempro Side Effects Report #5648715-1
Consumer or non-health professional from UNITED STATES reported PREMPRO problem on Feb 22, 2008. Female patient, weighting 131.1 lb, was treated with PREMPRO. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, antithrombin iii deficiency, atelectasis, cardiolipin antibody positive, deep vein thrombosis, gangrene, hypercoagulation, left ventricular end-diastolic pressure increased, . PREMPRO dosage: unknown. During the same period patient was treated with MEDROXYPROGESTERONE ACETATE, MEDROXYPROGESTERONE ACETATE, DICLOFENAC. Patient was hospitalized. Patient recovered.

Heparin Side Effects Report #5654702-X
HEPARIN problem was reported by a Pharmacist from UNITED STATES on Mar 07, 2008. Male patient, 73 years of age, was diagnosed with dialysis and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, haemorrhage, . HEPARIN dosage: unknown. Patient was hospitalized. Patient recovered.

Heparin Side Effects Report #5654709-2
Pharmacist from UNITED STATES reported HEPARIN problem on Mar 07, 2008. Male patient, 56 years of age, was diagnosed with haemodialysis and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, haemorrhage, procedural complication, . HEPARIN dosage: unknown. Patient was hospitalized. Patient recovered.

Heparin Side Effects Report #5654715-8
HEPARIN problem was reported by a Pharmacist from UNITED STATES on Mar 07, 2008. Male patient, 80 years of age, was diagnosed with haemodialysis and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, haemorrhage, . HEPARIN dosage: unknown. Patient was hospitalized. Patient recovered.


Heparin Side Effects Report #5654720-1
Pharmacist from UNITED STATES reported HEPARIN problem on Mar 07, 2008. Male patient, 73 years of age, was diagnosed with haemodialysis and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, haemorrhage, . HEPARIN dosage: unknown. Patient was hospitalized. Patient recovered.

Heparin Side Effects Report #5654721-3
HEPARIN problem was reported by a Pharmacist from UNITED STATES on Mar 07, 2008. Male patient, 53 years of age, was diagnosed with dialysis and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, haemorrhage, . HEPARIN dosage: unknown. Patient was hospitalized. Patient recovered.

Heparin Side Effects Report #5654724-9
Pharmacist from UNITED STATES reported HEPARIN problem on Mar 07, 2008. Female patient, 81 years of age, was diagnosed with haemodialysis and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, haemorrhage, . HEPARIN dosage: unknown. Patient was hospitalized. Patient recovered.

Xigris Side Effects Report #5657504-3
XIGRIS problem was reported by a Physician from UNITED STATES on Feb 27, 2008. Female patient, 42 years of age, was diagnosed with sepsis and was treated with XIGRIS. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, blood glucose increased, diabetic ketoacidosis, international normalised ratio increased, liver function test abnormal, sepsis, . XIGRIS dosage: unknown. During the same period patient was treated with CYMBALTA, ANTIBIOTICS, NEOSYNEPHRINE, LEVOPHED. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5657878-3
Consumer or non-health professional from JAPAN reported MEMANTINE problem on Feb 17, 2008. Male patient, 77 years of age, weighting 127.9 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, aspartate aminotransferase increased, blood urea increased, cardiac failure, cerebellar infarction, cerebral atrophy, cerebral haemorrhage, haemoglobin decreased, meningitis pneumococcal, . MEMANTINE dosage: unknown. During the same period patient was treated with ASPIRIN, AZULENE SULFONATE, CILOSTAZOL, ANTIBIOTICS, NIFEDIPINE, ETHYL ICOSAPENTATE, RILMAZAFONE HYDROCHLORIDE, WARFARIN. Patient was hospitalized and became disabled. Patient recovered.


Decitabine Side Effects Report #5657879-5
DECITABINE problem was reported by a Physician from TURKEY on Feb 22, 2008. Female patient, 64 years of age, weighting 163.1 lb, was treated with DECITABINE. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, caecitis, disease progression, febrile neutropenia, fibrin d dimer increased, haemorrhage intracranial, liver function test abnormal, platelet count decreased, prothrombin time prolonged, . DECITABINE dosage: 225 MG, INTRAVENOUS. During the same period patient was treated with PIPERACILLIN TAZOBACTAM, AMIKACIN, PRIMAXIN, NETILMICIN SULPHATE, DEFEROXAMINE. Patient was hospitalized and became disabled. Patient died on 03/22/2007.

Tysabri Side Effects Report #5660154-6
Physician from UNITED STATES reported TYSABRI problem on Feb 21, 2008. Female patient, 68 years of age, was diagnosed with multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, alanine aminotransferase increased, amnesia, aplastic anaemia, aspartate aminotransferase increased, atelectasis, bacterial infection, blood albumin decreased, blood alkaline phosphatase increased, . TYSABRI dosage: 300 MG; QM; IV. During the same period patient was treated with LISINOPRIL, AVONEX, TOPROL, FOSAMAX, ASPIRIN, PROVIGIL, VITAMIN D. Patient was hospitalized. Patient recovered.

Xigris Side Effects Report #5660746-4
XIGRIS problem was reported by a Physician from UNITED KINGDOM on Feb 27, 2008. Female patient, 34 years of age, was diagnosed with sepsis and was treated with XIGRIS. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, haemorrhage, thrombocytopenia, . XIGRIS dosage: unknown. Patient recovered.

Lipitor Side Effects Report #5660947-5
Physician from UNITED STATES reported LIPITOR problem on Feb 29, 2008. Male patient, weighting 145.1 lb, was diagnosed with blood cholesterol abnormal and was treated with LIPITOR. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, angina pectoris, anxiety, blood chloride increased, blood cholesterol increased, blood glucose increased, blood iron decreased, blood potassium decreased, blood pressure decreased, . LIPITOR dosage: unknown. During the same period patient was treated with COREG, ECOTRIN, XANAX, ISOSORBIDE MONONITRATE, BUMEX, COUMADIN, ALTACE. Patient was hospitalized. Patient recovered.

Angiomax Side Effects Report #5664136-X
ANGIOMAX problem was reported by a Physician from UNITED STATES on Feb 25, 2008. Male patient, 59 years of age, was diagnosed with coronary artery bypass, coagulopathy, haemorrhage and was treated with ANGIOMAX. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, akinesia, anoxic encephalopathy, atrial thrombosis, cardiac tamponade, coagulopathy, cranial nerve disorder, dilatation ventricular, grand mal convulsion, . ANGIOMAX dosage: 0.63 MG/KG, SINGLE, IV BOLUS. During the same period patient was treated with LEPIRUDIN, FACTOR VIIA, FACTOR VIIA, APROTININ, HEPARIN, EPINEPHRINE, DOPAMINE. Patient recovered.


Amevive Side Effects Report #5664313-8
Physician from UNITED STATES reported AMEVIVE problem on Feb 25, 2008. Male patient, 46 years of age, weighting 259.9 lb, was diagnosed with psoriasis and was treated with AMEVIVE. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, deep vein thrombosis, diarrhoea, international normalised ratio decreased, mass, musculoskeletal chest pain, pleural effusion, pneumonia, prothrombin time prolonged, . AMEVIVE dosage: 15 MG, WEEKLY, INTRAMUSCULAR. During the same period patient was treated with COUMADIN, LOVENOX. Patient was hospitalized. Patient recovered.

Oxaliplatin Side Effects Report #5669159-2
OXALIPLATIN problem was reported by a Health Professional from UNITED STATES on Mar 11, 2008. Male patient, 55 years of age, weighting 144.5 lb, was diagnosed with neoplasm malignant and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, aspartate aminotransferase increased, atrial fibrillation, blood bilirubin increased, blood calcium decreased, blood chloride decreased, blood glucose increased, blood pressure diastolic decreased, blood sodium decreased, . OXALIPLATIN dosage: 130 MG/M2 IV Q 21 D. During the same period patient was treated with DOCETAXEL, ALBUTEROL, ASPIRIN, COLESTIPOL HYDROCHLORIDE, FLUNISOLIDE, FOMOTEROL, LEVOTHYROXINE, METOPROLOL TARTRATE. Patient was hospitalized. Patient died.

Mabcampath Side Effects Report #5669186-5
Physician from SINGAPORE reported MABCAMPATH problem on Mar 11, 2008. Male patient, 46 years of age, was diagnosed with immunosuppression, renal transplant, prophylaxis and was treated with MABCAMPATH. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, azotaemia, coagulopathy, fluid overload, graft dysfunction, graft haemorrhage, hypotension, oliguria, . MABCAMPATH dosage: UNIT DOSE: 20 MG. During the same period patient was treated with PIRITION, ROCEPHIN, ANAESTHETICS, PROGRAF. Patient was hospitalized and became disabled. Patient recovered.

Mabcampath Side Effects Report #5670251-7
MABCAMPATH problem was reported by a Physician from SINGAPORE on Mar 11, 2008. Male patient, 46 years of age, was diagnosed with immunosuppression, renal transplant, prophylaxis and was treated with MABCAMPATH. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, azotaemia, coagulopathy, fluid overload, graft dysfunction, graft haemorrhage, hypotension, oliguria, . MABCAMPATH dosage: UNIT DOSE: 20 MG. During the same period patient was treated with PIRITION, ROCEPHIN, ANAESTHETICS, PROGRAF. Patient was hospitalized and became disabled. Patient recovered.

Xigris Side Effects Report #5671149-0
Physician from UNITED STATES reported XIGRIS problem on Mar 05, 2008. Female patient, 42 years of age, was diagnosed with sepsis, depression and was treated with XIGRIS. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, diabetes mellitus, diabetic ketoacidosis, international normalised ratio increased, liver function test abnormal, sepsis, . XIGRIS dosage: unknown. During the same period patient was treated with CYMBALTA. Patient was hospitalized. Patient recovered.


Argatroban Side Effects Report #5671888-1
ARGATROBAN problem was reported by a Consumer or non-health professional from JAPAN on Feb 27, 2008. Male patient, 60 years of age, was diagnosed with heparin-induced thrombocytopenia and was treated with ARGATROBAN. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, blood alkaline phosphatase abnormal, blood bilirubin abnormal, blood lactate dehydrogenase abnormal, gamma-glutamyltransferase abnormal, hepatic function abnormal, . ARGATROBAN dosage: unknown. During the same period patient was treated with AMPHOTERICIN B, ANTIBIOTICS. Patient was hospitalized and became disabled. Patient recovered.

Heparin Side Effects Report #5677093-7
Pharmacist from UNITED STATES reported HEPARIN ECTION problem on Mar 10, 2008. Male patient, 80 years of age, was diagnosed with haemodialysis and was treated with HEPARIN ECTION. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, haemorrhage, . HEPARIN ECTION dosage: 2,000 -10,000 UNITS/ML) VIA VASCULAR ACCES FOR HEMODIALYSIS. Patient recovered.

Heparin Side Effects Report #5677095-0
HEPARIN ECTION problem was reported by a Pharmacist from UNITED STATES on Mar 10, 2008. Male patient, 56 years of age, was diagnosed with haemodialysis and was treated with HEPARIN ECTION. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, haemorrhage, . HEPARIN ECTION dosage: (2,000 - 10,000 UNITS/ML), VIA VASCULAR ACCESS FOR HEMODIALYSIS. Patient recovered.

Heparin Side Effects Report #5677096-2
Pharmacist from UNITED STATES reported HEPARIN ECTION problem on Mar 10, 2008. Male patient, 53 years of age, was diagnosed with dialysis and was treated with HEPARIN ECTION. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, haemorrhage, . HEPARIN ECTION dosage: 2,000 - 10,000 UNITS/ML, VIA VASCULAR ACCESS FOR HEMODIALYSIS. Patient recovered.

Heparin Side Effects Report #5677097-4
HEPARIN ECTION problem was reported by a Pharmacist from UNITED STATES on Mar 10, 2008. Male patient, 73 years of age, was diagnosed with dialysis and was treated with HEPARIN ECTION. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, haemorrhage, . HEPARIN ECTION dosage: (2,000 - 10,000 UNITS/ML), VIA VASCULAR ACCESS FOR HEMODIALYSIS. Patient recovered.

Heparin Side Effects Report #5677098-6
Pharmacist from UNITED STATES reported HEPARIN ECTION problem on Mar 10, 2008. Female patient, 81 years of age, was diagnosed with haemodialysis and was treated with HEPARIN ECTION. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, haemorrhage, . HEPARIN ECTION dosage: (2,000 - 10,000 UNITS/ML), VIA VASCULAR ACCESS FOR HEMODIALYSIS. Patient recovered.

Heparin Side Effects Report #5677099-8
HEPARIN problem was reported by a Health Professional from UNITED STATES on Mar 24, 2008. Female patient was diagnosed with flushing and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, fibrin d dimer increased, platelet count decreased, prothrombin time prolonged, wound secretion, . HEPARIN dosage: 100 UNITS/ML FLUSH IV. Patient was hospitalized. Patient recovered.

Heparin Side Effects Report #5677100-1
Pharmacist from UNITED STATES reported HEPARIN ECTION problem on Mar 10, 2008. Male patient, 59 years of age, was diagnosed with haemodialysis and was treated with HEPARIN ECTION. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, haemorrhage, . HEPARIN ECTION dosage: (2,000 - 10,000 UNITS/ML), VIA VASCULAR ACCESS FOR HEMODIALYSIS. Patient recovered.

Heparin Side Effects Report #5677107-4
HEPARIN ECTION problem was reported by a Pharmacist from UNITED STATES on Mar 10, 2008. Male patient, 72 years of age, was diagnosed with haemodialysis and was treated with HEPARIN ECTION. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, haemorrhage, . HEPARIN ECTION dosage: (2,000 - 10,000 UNITS/ML), VIA VASCULAR ACCESS FOR HEMODIALYSIS. Patient recovered.

Erlotinib Side Effects Report #5677814-3
Physician from UNITED STATES reported ERLOTINIB problem on Mar 04, 2008. Male patient, 75 years of age, was diagnosed with hepatoblastoma and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, anaemia, blood blister, fibrin d dimer increased, haematoma, mass, metastasis, prothrombin time prolonged, sarcoma, . ERLOTINIB dosage: 150 MG QD ORAL. During the same period patient was treated with BEVACIZUMAB, LOVENOX, DEXAMETHASONE, GLIPIZIDE, SIMVASTATIN, NADOLOL, OXYBUTYNIN CHLORIDE. Patient was hospitalized. Patient recovered.

Prograf Side Effects Report #5678894-1
PROGRAF problem was reported by a Physician from UNITED STATES on Mar 10, 2008. Female patient, 47 years of age, was diagnosed with lung transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, blood ph decreased, breath sounds absent, cardiac arrest, catatonia, catheter bacteraemia, constipation, depression, haematocrit decreased, . PROGRAF dosage: 2 MG, BID, ORAL. During the same period patient was treated with PREDNISOLONE ACETATE, AZITHROMYCIN, MAXALT, FERROUS SULPHATE, PROTONIX, ARANESP, VITAMIN B, BUDESONIDE. Patient was hospitalized. Patient died on 10/21/2007.

Trisenox Side Effects Report #5680028-4
Physician from JAPAN reported TRISENOX problem on Mar 12, 2008. Male patient, 63 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with TRISENOX. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, acute promyelocytic leukaemia, alanine aminotransferase increased, aspartate aminotransferase increased, blood albumin decreased, blood alkaline phosphatase increased, blood bilirubin increased, blood calcium decreased, blood lactate dehydrogenase increased, . TRISENOX dosage: K9.75 MG QD; INTRAVENOUS. During the same period patient was treated with ARBEKACIN SULPHATE, MEROPENEM, MEXILETINE HYDROCHLORIDE, DALTEPARIN, HYDROCORTISONE SUCCINATE, RANITIDINE HYDROCHLORIDE, ALLOPURINOL. Patient was hospitalized. Patient died on 05/10/2007.

Tysabri Side Effects Report #5683543-2
TYSABRI problem was reported by a Physician from GERMANY on Mar 17, 2008. Female patient, 33 years of age, weighting 134.5 lb, was diagnosed with multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, blood glucose increased, convulsion, depression, disorientation, hypothyroidism, prothrombin time prolonged, thrombosis, tongue injury, . TYSABRI dosage: 300 MG; QM; IV. During the same period patient was treated with MARCUMAR, MIRTAZAPINE. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #5684414-8
Consumer or non-health professional from UNITED STATES reported CETUXIMAB problem on Nov 27, 2006. Male patient, 75 years of age, weighting 149.9 lb, was diagnosed with non-small cell lung cancer and was treated with CETUXIMAB. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, alanine aminotransferase increased, atelectasis, blood alkaline phosphatase increased, blood magnesium decreased, blood potassium decreased, diarrhoea, failure to thrive, . CETUXIMAB dosage: unknown. During the same period patient was treated with DOCETAXEL. Patient was hospitalized. Patient recovered.

Arixtra Side Effects Report #5611028-8
ARIXTRA problem was reported by a Consumer or non-health professional from FRANCE on Jan 22, 2008. Female patient, 67 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with ARIXTRA. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, haematoma, haemoglobin decreased, incorrect dose administered, . ARIXTRA dosage: 7.5MG PER DAY. During the same period patient was treated with PREVISCAN, SERETIDE DISKUS, PHYSIOTENS, ISOPTIN. Patient was hospitalized. Patient recovered.

Arixtra Side Effects Report #5615094-5
Consumer or non-health professional from UNITED STATES reported ARIXTRA problem on Mar 28, 2007. Female patient, 82 years of age, was treated with ARIXTRA. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, adverse event, . ARIXTRA dosage: 2.5MG ALTERNATE DAYS. Patient recovered.

Erlotinib Side Effects Report #5616248-4
ERLOTINIB problem was reported by a Physician from UNITED STATES on Jan 29, 2008. Male patient, 79 years of age, was diagnosed with non-small cell lung cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, aortic embolus, clostridium difficile sepsis, deep vein thrombosis, . ERLOTINIB dosage: unknown. During the same period patient was treated with INDERAL LA, PLAVIX, VYTORIN, LISINOPRIL, BEVACIZUMAB. Patient was hospitalized. Patient recovered.

Paxil Side Effects Report #5623097-X
Consumer or non-health professional from UNITED STATES reported PAXIL problem on Jan 30, 2008. Female patient, weighting 7.50 lb, was diagnosed with anxiety and was treated with PAXIL. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, asthma, atrial septal defect, cardiac disorder, cardiac failure congestive, cardiac murmur, cyanosis, disease complication, . PAXIL dosage: 20MG PER DAY. During the same period patient was treated with XOPENEX, CLARITIN, CLARINEX, PULMICORT, PRENATAL VITAMINS, ALDOMET. Patient was hospitalized. Patient recovered.

Oxycodone Side Effects Report #5623742-9
OXYCODONE problem was reported by a Physician from UNITED STATES on Jan 07, 2008. Male patient, 43 years of age, was treated with OXYCODONE. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, acute abdomen, aggression, agitation, alanine aminotransferase increased, ammonia increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood amylase increased, . OXYCODONE dosage: unknown. Patient was hospitalized. Patient died.

Prezolon Side Effects Report #5624216-1
Consumer or non-health professional from GREECE reported PREZOLON problem on Feb 08, 2008. Female patient, child 7 years of age, was diagnosed with vasculitis and was treated with PREZOLON. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, blood urea increased, fibrin d dimer increased, haematocrit decreased, haemoglobin decreased, histiocytosis haematophagic, immunosuppression, parvovirus b19 serology positive, parvovirus infection, . PREZOLON dosage: unknown. During the same period patient was treated with METHYLPREDNISOLONE, KINERET, CORTICOSTEROIDS, METHOTREXATE, CYCLOPHOSPHAMIDE, ENBREL, AZATHIOPRINE, SANDIMMUNE. Patient died on 05/12/2007.

Warfarin Side Effects Report #5627160-9
WARFARIN problem was reported by a Pharmacist from UNITED STATES on Feb 13, 2008. Female patient, 92 years of age, weighting 110.2 lb, was diagnosed with atrial fibrillation and was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, asthenia, haematocrit decreased, haematuria, haemoglobin decreased, pallor, prothrombin time prolonged, rectal haemorrhage, . WARFARIN dosage: 5 MG DAILY PO. Patient was hospitalized. Patient recovered.

Thymoglobulin Side Effects Report #5631658-7
Physician from UNITED STATES reported THYMOGLOBULIN problem on Jan 28, 2008. Female patient, 14 years of age, was diagnosed with renal transplant and was treated with THYMOGLOBULIN. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, blood amylase increased, blood bilirubin increased, blood pressure decreased, complications of transplanted kidney, haemolysis, hepatic function abnormal, hypoxia, international normalised ratio abnormal, . THYMOGLOBULIN dosage: 1.5 MG/KG, QD, INTRAVENOUS, 1.5 MG/KG, ONCE, INTRAVENOUS. During the same period patient was treated with ACETAMINOPHEN, BACTRIM, BENADRYL, PHENERGAN, DILAUDID, ZOFRAN. Patient recovered.

Ciprofloxacin Side Effects Report #5633805-X
CIPROFLOXACIN problem was reported by a Consumer or non-health professional from on Feb 04, 2008. Female patient, 18 years of age, was treated with CIPROFLOXACIN. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, international normalised ratio increased, nephritis interstitial, vomiting, . CIPROFLOXACIN dosage: unknown. During the same period patient was treated with RIFAMPICIN. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5633808-5
Consumer or non-health professional from JAPAN reported MEMANTINE problem on Jan 30, 2008. Male patient, 77 years of age, weighting 127.9 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, altered state of consciousness, aspartate aminotransferase increased, blood creatine phosphokinase increased, blood glucose increased, blood lactate dehydrogenase increased, blood magnesium increased, blood sodium decreased, blood urea increased, . MEMANTINE dosage: unknown. During the same period patient was treated with ASPIRIN, AZULENE SULFONATE, CILOSTAZOL, ANTIBIOTICS, NIFEDIPINE, ETHYL ICOSAPENTATE, RILMAZAFONE HYDROCHLORIDE, WARFARIN. Patient was hospitalized and became disabled. Patient recovered.

Avonex Side Effects Report #5634059-0
AVONEX problem was reported by a Consumer or non-health professional from GERMANY on Feb 01, 2008. Female patient, 28 years of age, was diagnosed with multiple sclerosis and was treated with AVONEX. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, gamma-glutamyltransferase increased, white blood cell count decreased, . AVONEX dosage: unknown. Patient recovered.

Fosamax Side Effects Report #5638832-4
Physician from UNITED STATES reported FOSAMAX problem on Feb 15, 2008. Female patient, 72 years of age, was diagnosed with osteoporosis and was treated with FOSAMAX. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, anaemia of chronic disease, bronchitis, bursitis, cardiac failure congestive, chronic obstructive pulmonary disease, colitis ischaemic, compression fracture, deafness, . FOSAMAX dosage: unknown. Patient was hospitalized. Patient recovered.

Exjade Side Effects Report #5638968-8
EXJADE problem was reported by a Health Professional from SWEDEN on Feb 18, 2008. Male patient, 83 years of age, was diagnosed with serum ferritin increased and was treated with EXJADE. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, anuria, azotaemia, biopsy kidney, blood creatinine increased, blood glucose increased, blood urea increased, c-reactive protein increased, catheter site haemorrhage, . EXJADE dosage: unknown. During the same period patient was treated with DESFERAL, WARAN, MINDIAB, DIGOXIN, TENORMIN. Patient was hospitalized. Patient recovered.

Heparin Side Effects Report #5642645-7
Pharmacist from UNITED STATES reported HEPARIN problem on Feb 28, 2008. Male patient, 52 years of age, weighting 191.8 lb, was diagnosed with acute coronary syndrome and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, gastric haemorrhage, . HEPARIN dosage: unknown. During the same period patient was treated with EPTIFIBATIDE. Patient was hospitalized. Patient recovered.

Heparin Side Effects Report #5644293-1
HEPARIN problem was reported by a Pharmacist from UNITED STATES on Feb 29, 2008. Male patient, 64 years of age, weighting 166.4 lb, was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, haemoglobin decreased, post procedural haemorrhage, . HEPARIN dosage: unknown. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5645621-3
Physician from JAPAN reported MYLOTARG problem on Feb 18, 2008. Male patient, weighting 116.8 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, blood albumin decreased, blood alkaline phosphatase increased, blood cholinesterase decreased, blood lactate dehydrogenase increased, blood potassium decreased, . MYLOTARG dosage: unknown. During the same period patient was treated with PREDNISOLONE, PARIET, BAKTAR, METHOTREXATE, DIFLUCAN, CIPROFLOXACIN, GLYSENNID. Patient was hospitalized and became disabled. Patient recovered.

Coumadin Side Effects Report #5646578-1
COUMADIN problem was reported by a Pharmacist from UNITED STATES on Feb 28, 2008. Female patient, weighting 195.0 lb, was diagnosed with heart rate irregular and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, international normalised ratio increased, pain in extremity, prothrombin time prolonged, . COUMADIN dosage: unknown. During the same period patient was treated with DILTIAZEM, PROTONIX, FOSINOPRIL, ATENOLOL, NITROFURANTOIN, NITROGLYCERIN, ALBUTEROL. Patient was hospitalized. Patient recovered.

Angiomax Side Effects Report #5655672-0
Physician from UNITED STATES reported ANGIOMAX problem on Nov 09, 2007. Male patient, 71 years of age, was diagnosed with therapeutic procedure and was treated with ANGIOMAX. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, international normalised ratio increased, . ANGIOMAX dosage: 1 MG/KG, HR, INTRAVENOUS. During the same period patient was treated with RETEPLASE, HEPARIN. Patient recovered.